Multiple Sclerosis: Diagnosis and Misdiagnosis |
03/25/2021 - 7:30am to 8:30am |
“The Role of TREM2 and APOE in the brain’s innate immune response to Alzheimer’s type pathology” |
03/18/2021 - 7:30am to 8:30am |
A Journey from a Voxel to a Clinical Application for Parkinsonism |
03/11/2021 - 7:30am to 8:30am |
Current Research and Therapeutic Strategies for the Treatment and Prevention of Alzheimer’s Disease and Related Disorders |
03/04/2021 - 7:30am to 8:30am |
ICU EEG: Connecting Seizures to Outcomes |
02/25/2021 - 7:30am to 8:30am |
A Clinical Approach to Acute Symptomatic Seizures Secondary to Autoimmune Encephalitis and Autoimmune-Associated Epilepsy |
02/18/2021 - 7:30am to 8:30am |
Deep Brain Stimulation in Managing Patients with Parkinson’s Disease: An updated Overview for Clinical Practice |
02/11/2021 - 7:30am to 8:30am |
Clinical Genetic Testing in PD - Are We Ready ? |
02/04/2021 - 7:30am to 8:30am |
Deep phenotyping in people with multiple sclerosis to identify subgroups and improve outcomes |
01/28/2021 - 7:30am to 8:30am |
Antagonism of the Neonatal Fc Receptor (Fcrn) for the Treatment Of MG |
12/17/2020 - 7:30am to 8:30am |